Nexalin Technology Stock Price To Earnings To Growth

NXL Stock  USD 3.82  0.08  2.05%   
Nexalin Technology fundamentals help investors to digest information that contributes to Nexalin Technology's financial success or failures. It also enables traders to predict the movement of Nexalin Stock. The fundamental analysis module provides a way to measure Nexalin Technology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nexalin Technology stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Nexalin Technology Company Price To Earnings To Growth Analysis

Nexalin Technology's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.

Nexalin Price To Earnings To Growth Driver Correlations

Understanding the fundamental principles of building solid financial models for Nexalin Technology is extremely important. It helps to project a fair market value of Nexalin Stock properly, considering its historical fundamentals such as Price To Earnings To Growth. Since Nexalin Technology's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nexalin Technology's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nexalin Technology's interrelated accounts and indicators.
0.950.84-0.48-0.710.230.07-0.011.0-0.220.90.83-0.790.990.710.910.96-0.36-0.36
0.950.96-0.63-0.8-0.040.05-0.30.95-0.490.910.95-0.760.980.730.941.0-0.6-0.6
0.840.96-0.8-0.89-0.210.16-0.490.83-0.70.91.0-0.770.90.80.950.95-0.78-0.78
-0.48-0.63-0.80.930.19-0.610.49-0.460.83-0.77-0.820.79-0.54-0.89-0.79-0.630.890.89
-0.71-0.8-0.890.93-0.03-0.560.29-0.70.66-0.9-0.910.9-0.74-0.93-0.91-0.820.820.82
0.23-0.04-0.210.19-0.030.460.940.240.710.16-0.22-0.350.110.190.070.00.470.47
0.070.050.16-0.61-0.560.460.240.07-0.160.390.18-0.660.050.680.350.08-0.33-0.33
-0.01-0.3-0.490.490.290.940.240.00.89-0.14-0.49-0.03-0.13-0.14-0.23-0.260.70.7
1.00.950.83-0.46-0.70.240.070.0-0.210.90.82-0.780.990.70.90.96-0.35-0.35
-0.22-0.49-0.70.830.660.71-0.160.89-0.21-0.47-0.720.36-0.33-0.53-0.53-0.470.90.9
0.90.910.9-0.77-0.90.160.39-0.140.9-0.470.9-0.940.920.930.990.92-0.57-0.57
0.830.951.0-0.82-0.91-0.220.18-0.490.82-0.720.9-0.770.880.810.940.94-0.8-0.8
-0.79-0.76-0.770.790.9-0.35-0.66-0.03-0.780.36-0.94-0.77-0.78-0.98-0.92-0.780.520.52
0.990.980.9-0.54-0.740.110.05-0.130.99-0.330.920.88-0.780.720.930.98-0.44-0.44
0.710.730.8-0.89-0.930.190.68-0.140.7-0.530.930.81-0.980.720.920.75-0.64-0.64
0.910.940.95-0.79-0.910.070.35-0.230.9-0.530.990.94-0.920.930.920.95-0.63-0.63
0.961.00.95-0.63-0.820.00.08-0.260.96-0.470.920.94-0.780.980.750.95-0.59-0.59
-0.36-0.6-0.780.890.820.47-0.330.7-0.350.9-0.57-0.80.52-0.44-0.64-0.63-0.591.0
-0.36-0.6-0.780.890.820.47-0.330.7-0.350.9-0.57-0.80.52-0.44-0.64-0.63-0.591.0
Click cells to compare fundamentals
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Competition

Nexalin Price Earnings To Growth Ratio

Price Earnings To Growth Ratio

(0.004277)

At this time, Nexalin Technology's Price Earnings To Growth Ratio is quite stable compared to the past year.
Based on the latest financial disclosure, Nexalin Technology has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.

Nexalin Price To Earnings To Growth Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nexalin Technology's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nexalin Technology could also be used in its relative valuation, which is a method of valuing Nexalin Technology by comparing valuation metrics of similar companies.
Nexalin Technology is currently under evaluation in price to earnings to growth category among its peers.

Nexalin Technology ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Nexalin Technology's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Nexalin Technology's managers, analysts, and investors.
Environmental
Governance
Social

Nexalin Fundamentals

About Nexalin Technology Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Nexalin Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nexalin Technology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nexalin Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Nexalin Technology is a strong investment it is important to analyze Nexalin Technology's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nexalin Technology's future performance. For an informed investment choice regarding Nexalin Stock, refer to the following important reports:
Check out Nexalin Technology Piotroski F Score and Nexalin Technology Altman Z Score analysis.
For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. If investors know Nexalin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexalin Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.65)
Revenue Per Share
0.02
Quarterly Revenue Growth
(0.24)
Return On Assets
(1.19)
Return On Equity
(2.02)
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexalin Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexalin Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexalin Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.